GNS Healthcare
(Redirected from Gene Network Sciences)
 | |
| Company type | Private (subsidiary of Via Science) |
|---|---|
| Founded | Ithaca, New York, USA (2000) |
| Founder | Colin Hill (CEO) Iya Khalil |
| Headquarters | , USA |
| Website | https://www.aitiabio.com/ |
Aitia (f.k.a GNS Healthcare) is a biosimulation company based in Somerville, MA.
A company called Gene Network Sciences (GNS), was founded in 2000 by Cornell physicists Colin Hill and Iya Khalil, which focused on computational biology models of interactions among genes and proteins in cells, with a focus on cancer drug discovery.[1]
Aitia was formed as a subsidiary of GNS in 2010 to apply the data analytic methods the company had developed to the healthcare provider, health insurance, pharmacy benefit management and health informatics industries.[2]
References
[edit]- ^ Friedlander, Blaine (October 21, 2002). "Gene Network Sciences, company started and funded by Cornell students, gets $2 million federal grant for cancer research". Cornell Chronicle.
- ^ McBride, Ryan (27 April 2010). "Gene Network Sciences Using Supercomputing to Match Patients with a Drug That Works". Xconomy.
Further reading
[edit]- Kolakowski, Nick (September 26, 2012) "GNS Healthcare, Aetna Team on Analytics to Combat Metabolic Syndrome". "Slashdot".
- Cambia Health Solutions (April 18, 2012) "Cambia Health Solutions Announces Investment in GNS Healthcare". (Press release).
- Miller, Katherine (January 2, 2012) "Big Data Analytics In Biomedical Research". Biomedical Computation Review.
- Council on Competitiveness (June 30, 2011) "Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare" (Press release).
External links
[edit] | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |